C1ORF163 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.865400E-01
Normal-vs-Stage2
4.986200E-01
Normal-vs-Stage3
6.881600E-01
Normal-vs-Stage4
1.734040E-02
Stage1-vs-Stage2
5.149800E-01
Stage1-vs-Stage3
3.361800E-01
Stage1-vs-Stage4
1.175910E-03
Stage2-vs-Stage3
2.323600E-01
Stage2-vs-Stage4
1.098810E-03
Stage3-vs-Stage4
1.878220E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.264600E-01
Normal-vs-AfricanAmerican
3.287400E-01
Normal-vs-Asian
8.597000E-01
Caucasian-vs-AfricanAmerican
4.058200E-01
Caucasian-vs-Asian
1.460840E-01
AfricanAmerican-vs-Asian
6.128500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.891800E-01
Normal-vs-Female
4.764200E-01
Male-vs-Female
3.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.996400E-01
Normal-vs-Age(41-60Yrs)
4.221000E-01
Normal-vs-Age(61-80Yrs)
5.858000E-01
Normal-vs-Age(81-100Yrs)
5.850000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.172600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.839800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.765800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.581800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.196000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.652200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.833200E-01
Normal-vs-Daily Drinker
8.493400E-01
Normal-vs-Weekly Drinker
6.107600E-01
Normal-vs-Occasional Drinker
3.869200E-01
Normal-vs-Social Drinker
5.276000E-01
Non Drinker-vs-Daily Drinker
9.437200E-01
Non Drinker-vs-Weekly Drinker
4.684200E-01
Non Drinker-vs-Occasional Drinker
1.594990E-01
Non Drinker-vs-Social Drinker
3.120000E-01
Daily Drinker-vs-Weekly Drinker
5.071800E-01
Daily Drinker-vs-Occasional Drinker
1.835610E-01
Daily Drinker-vs-Social Drinker
3.471800E-01
Weekly Drinker-vs-Occasional Drinker
6.082400E-01
Weekly Drinker-vs-Social Drinker
8.125000E-01
Occasional Drinker-vs-Social Drinker
8.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.510400E-01
Normal-vs-Grade 2
8.940000E-01
Normal-vs-Grade 3
8.681400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.317800E-02
Grade 1-vs-Grade 3
3.184400E-02
Grade 1-vs-Grade 4
9.510400E-01
Grade 2-vs-Grade 3
6.474200E-01
Grade 2-vs-Grade 4
8.940000E-01
Grade 3-vs-Grade 4
8.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.234000E-01
Normal-vs-NonDiabetic
6.818400E-01
Diabetic-vs-NonDiabetic
4.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.803400E-01
Normal-vs-NoPancreatitis
6.058800E-01
Pancreatitis-vs-NoPancreatitis
4.448600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.216000E-01
Normal-vs-N1
4.448600E-01
N0-vs-N1
1.452190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.938000E-01
Normal-vs-TP53-NonMutant
6.462600E-01
TP53-Mutant-vs-TP53-NonMutant
1.342580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
